A Study to Evaluate a New Tablet Formulation of Lu AG06466 in Healthy Participants
Status:
Recruiting
Trial end date:
2021-10-31
Target enrollment:
Participant gender:
Summary
The main goal of this trial is to learn how a new tablet formulation of Lu AG06466 behaves in
the body. Researchers will compare the new tablet formulation to the capsule formulation that
is currently being tested in other clinical trials. They will measure the levels of the drug
in the bloodstream for up to 3 days after participants take either the tablet or the capsule
formulation. They will also look at whether the tablet formulation behaves differently when
it is taken with and without food.